Germany · Delayed Price · Currency is EUR enVVeno Medical Statistics
Total Valuation
enVVeno Medical has a market cap or net worth of EUR 6.91 million. The enterprise value is -19.03 million.
| Market Cap | 6.91M |
| Enterprise Value | -19.03M |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 20.22M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +27.53% |
| Shares Change (QoQ) | -0.97% |
| Owned by Insiders (%) | 4.60% |
| Owned by Institutions (%) | 14.08% |
| Float | 14.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.28 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.02 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.30 |
Financial Position
The company has a current ratio of 13.12, with a Debt / Equity ratio of 0.03.
| Current Ratio | 13.12 |
| Quick Ratio | 12.90 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.19% and return on invested capital (ROIC) is -36.90%.
| Return on Equity (ROE) | -57.19% |
| Return on Assets (ROA) | -35.12% |
| Return on Invested Capital (ROIC) | -36.90% |
| Return on Capital Employed (ROCE) | -77.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -505,967 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -90.26% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 2.26 |
| Relative Strength Index (RSI) | 26.11 |
| Average Volume (20 Days) | 250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.82M |
| Pretax Income | -18.72M |
| Net Income | -18.72M |
| EBITDA | -19.69M |
| EBIT | -19.82M |
| Earnings Per Share (EPS) | -0.92 |
Balance Sheet
The company has 26.38 million in cash and 674,169 in debt, giving a net cash position of 25.71 million.
| Cash & Cash Equivalents | 26.38M |
| Total Debt | 674,169 |
| Net Cash | 25.71M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.10M |
| Book Value Per Share | 1.24 |
| Working Capital | 24.80M |
Cash Flow
In the last 12 months, operating cash flow was -14.69 million and capital expenditures -7,671, giving a free cash flow of -14.69 million.
| Operating Cash Flow | -14.69M |
| Capital Expenditures | -7,671 |
| Free Cash Flow | -14.69M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
enVVeno Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.53% |
| Shareholder Yield | -27.53% |
| Earnings Yield | -270.76% |
| FCF Yield | -212.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 30, 2020. It was a reverse split with a ratio of 0.04.
| Last Split Date | Nov 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |